Multicenter study to determine antibody concentrations and assess the safety of administration of INH-A21, a donor-selected human staphylococcal immune globulin, in low-birth-weight infants

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 10, 2005, Pages 4121-4127

  Capparelli, Edmund V ^a   Bloom, Barry T ^b   Kueser, Tom J ^c   Oelberg, David G ^d   Bifano, Ellen M ^e   White, Robert D ^f   Schelonka, Robert L ^g   Pearlman, Stephen A ^h   Patti, Joseph ⁱ   Hetherington, Seth V ⁱ  

^a Trials by Design LLC   (United States)

^b WESLEY MEDICAL CENTER   (United States)

^c CAROLINAS MEDICAL CENTER   (United States)

^d EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^e UMU Syracuse   (United States)

^f is an assistant professor of nursing at Bethel College   (United States)

^g UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^h CHRISTIANA CARE HEALTH SYSTEM   (United States)

ⁱ Inhibitex Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; INH A21; VERONATE;

ANTIBODY DETECTION; ARTICLE; BACTERIAL INFECTION; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; HOSPITAL INFECTION; HUMAN; HYPERTENSION; HYPOGLYCEMIA; LOW BIRTH WEIGHT; MULTICENTER STUDY; NEWBORN; NEWBORN INFECTION; NEWBORN SEPSIS; OPEN STUDY; PHASE 1 CLINICAL TRIAL; PREMATURITY; PRIORITY JOURNAL; STAPHYLOCOCCUS INFECTION; TREATMENT OUTCOME;

ANTIBODIES, BACTERIAL; BAYES THEOREM; HALF-LIFE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; KINETICS; MULTICENTER STUDIES; RANDOMIZED CONTROLLED TRIALS; SEPSIS; STAPHYLOCOCCAL INFECTIONS; UNITED STATES;

EID: 25844451014     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.10.4121-4127.2005     Document Type: Article

References (23)

1. Anonymous. 1997. Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. Pediatrics 99:93-99.
2. Baker, C. J., M. E. Melish, R. T. Hall, D. T. Casto, U. Vasan, L. B. Givner, et al. 1992. Intravenous immune globulin for the prevention of nosocomial infection in low-birth-weight neonates. N. Engl. J. Med. 327:213-219.
3. Barton, L., J. E. Hodgman, and Z. Pavlova. 1999. Causes of death in the extremely low birth weight infant. Pediatrics 103:446-451.
4. Capparelli, E. V., and J. D. Connor. 2002. Population pharmacokinetics of IVIG in premature infants using an endogenous IgG production model. Clin. Pharmacol. Ther. 71:P4.
5. Fanaroff, A. A., M. Hack, and M. C. Walsh. 2003. The NICHD neonatal research network: changes in practice and outcomes during the first 15 years. Semin. Perinatol. 27:281-287.
6. Fanaroff, A. A., S. B. Korones, L. L. Wright, J. Verter, R. L. Poland, C. R. Bauer, J. E. Tyson, J. B. Philips III, W. Edwards, J. F. Lucey, C. S. Catz, S. Shankaran, and W. Oh. 1998. Incidence, presenting features, risk factors and significance of late onset septicemia in very low birth weight infants. Pediatr. Infect. Dis. J. 17:593-598.
7. Fanaroff, A. A., S. B. Korones, L. L. Wright, E. C. Wright, R. L. Poland, C. B. Bauer, J. E. Tyson, J. B. Philips III, W. Edwards, and J. F. Lucey. 1994. A controlled trial of intravenous immune globulin to reduce nosocomial infections in very-low-birth-weight infants. N. Engl. J. Med. 330:1107-1113.
8. Healy, C. M., D. L. Palazzi, M. S. Edwards, J. R. Campbell, and C. J. Baker. 2004. Features of invasive staphylococcal disease in neonates. Pediatrics 114:953-961.
9. Hill, H. R. 1993. Intravenous immunoglobulin use in the neonate: role in prophylaxis and therapy of infection. Pediatr. Infect. Dis. J. 12:549-558.
10. Jenson, H. B., and B. H. Pollock. 1997. Meta-analyses of the effectiveness of intravenous immune globulin for prevention and treatment of neonatal sepsis. Pediatrics 99:E2.
11. Koffman, B. M., and M. C. Dalakas. 1997. Effect of high-dose intravenous immunoglobulin on serum chemistry, hematology, and lymphocyte subpopulations: assessments based on controlled treatment trials in patients with neurological diseases. Muscle Nerve 20:1102-1107.
12. Lassiter, H. A. 1992. Intravenous immunoglobulin in the prevention and treatment of neonatal bacterial sepsis. Adv. Pediatr. 39:71-99.
13. Lemons, J. A., C. R. Bauer, W. Oh, S. B. Korones, L. A. Papile, B. J. Stoll, J. Verter, M. Temprosa, L. L. Wright, R. A. Ehrenkranz, A. A. Fanaroff, A. Stark, W. Carlo, J. E. Tyson, E. F. Donovan, S. Shankaran, and D. K. Stevenson. 2001. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1995 through December 1996. Pediatrics 107:E1.
14. Ohlsson, A., and J. B. Lacy. 2001. Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants. Cochrane Database Syst. Rev., CD000361.
15. Ohlsson, A., and J. B. Lacy. 2004. Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants. Cochrane Database Syst. Rev., CD000361. (Update.)
16. Patrick, C. C., S. L. Kaplan, C. J. Baker, J. T. Parisi, and E. O. Mason, Jr. 1989. Persistent bacteremia due to coagulase-negative staphylococci in low birth weight neonates. Pediatrics 84:977-985.
17. Patti, J. M., B. L. Allen, M. J. McGavin, and M. Hook. 1994. MSCRAMM-mediated adherence of microorganisms to host tissues. Annu. Rev. Microbiol. 48:585-617.
18. Patti, J. M., and M. Hook. 1994. Microbial adhesins recognizing extracellular matrix macromolecules. Curr. Opin. Cell Biol. 6:752-758.
19. Reilley, S., E. Wenzel, L. Reynolds, B. Bennett, J. M. Patti, and S. Hetherington. 2005. Open-label, dose escalation study of the safety and pharmacokinetic profile of tefibazumab in healthy volunteers. Antimicrob. Agents Chemother. 49:959-962.
20. Shurin, P. A., J. M. Rehmus, C. E. Johnson, C. D. Marchant, S. A. Carlin, D. M. Super, G. F. Vanhare, P. K. Jones, D. M. Ambrosino, and G. R. Siber. 1993. Bacterial polysaccharide immune globulin for prophylaxis of acute otitis media in high-risk children. J. Pediatr. 123:801-810.
21. Stoll, B. J., N. Hansen, A. A. Fanaroff, L. L. Wright, W. A. Carlo, R. A. Ehrenkranz, J. A. Lemons, E. F. Donovan, A. R. Stark, J. E. Tyson, W. Oh, C. R. Bauer, S. B. Korones, S. Shankaran, A. R. Laptook, D. K. Stevenson, L. A. Papile, and W. K. Poole. 2002. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 110:285-291.
22. Stoll, B. J., N. I. Hansen, I. Adams-Chapman, A. A. Fanaroff, S. R. Hintz, B. Vohr, and R. D. Higgins. 2004. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 292:2357-2365.
23. Wilson, J. R., H. Bhoopalam, and M. Fisher. 1997. Hemolytic anemia associated with intravenous immunoglobulin. Muscle Nerve 20:1142-1145.